Dr Reddys Laboratories (RDY) Cash & Equivalents (QoQ) (2009 - 2023)
Dr Reddys Laboratories (RDY) Cash & Equivalents (QoQ) (2009 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -2.10% |
| Jun 30, 2022 | 120.41% |
| Mar 31, 2021 | -30.24% |
| Dec 31, 2020 | -18.49% |
| Mar 31, 2020 | -90.36% |
| Dec 31, 2019 | -34.43% |
| Mar 31, 2019 | -91.09% |
| Jun 30, 2018 | -27.62% |
| Mar 31, 2018 | -100.00% |
| Dec 31, 2017 | 30.80% |
| Sep 30, 2017 | 116,371,681,415,829.20% |
| Jun 17, 2017 | 80,426,946.26% |
| Mar 17, 2017 | -100.00% |
| Dec 31, 2016 | -5.71% |
| Dec 31, 2015 | 11.87% |
| Sep 30, 2015 | -6.88% |
| Jun 30, 2015 | -11.54% |
| Mar 31, 2015 | -100.00% |
| Dec 31, 2014 | 0.00% |
| Dec 31, 2013 | 14.81% |